The Science of Selective Estrogen Receptor Modulators: Concept to Clinical Practice

Lippman et al. ([1][1]) assess the effect of raloxifene on the incidence of breast cancer in women with defined risk factors. However, raloxifene is used in clinical practice for the treatment and prevention of osteoporosis in postmenopausal women. To the casual observer, the application of a